Concepedia
Statistics
Publications
8
Citations
2K
H-Index
Active since
2009
Affiliations
Biogen (United States)(Current)
Brigham and Women's Hospital
Novartis Foundation
Massachusetts College of Pharmacy and Health Sciences
Amgen (United States)
James Scanlon is an author at Biogen (United States) specializing in multiple sclerosis, pharmacotherapy, and antibodies.
Publications per year
2009–2021
Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
Gary Bloomgren, Sandra Richman, Christophe Hotermans et al. · New England Journal of Medicine · 2012 · 1.2K citations · Full text
Life Sciences, Neurology, Pharmacotherapy +17
Hypoglycemia and Clinical Outcomes in Patients With Diabetes Hospitalized in the General Ward
Alexander Turchin, Michael E. Matheny, Maria Shubina et al. · Diabetes Care · 2009 · 452 citations · Full text
Medicine, Internal Medicine, Diabetology +10
Anti‐John Cunnigham virus antibody prevalence in multiple sclerosis patients: Baseline results of STRATIFY‐1
Carmen Bozic, Sandra Richman, Tatiana Plavina et al. · Annals of Neurology · 2011 · 143 citations
Life Sciences, Immunology, Infectious Diseases +17
Alexander Turchin, Michael E. Matheny, Maria Shubina et al. · Diabetes Care · 2009 · 61 citations · Full text
Low-contrast acuity measures visual improvement in phase 3 trial of natalizumab in relapsing MS
Laura J. Balcer, Steven Galetta, Chris H. Polman et al. · Journal of the Neurological Sciences · 2012 · 58 citations
Medicine, Neurology, Ophthalmology +12
1–5 of 8